NASDAQ
DMTK

DermTech Inc

SERVICES-MEDICAL LABORATORIES
LIFE SCIENCES

Prices are adjusted according to historical splits.

DermTech Inc Stock Price

Vitals

Today's Low:
$3.0600
Today's High:
$3.2900
Open Price:
$3.2200
52W Low:
$2.81
52W High:
$30.11
Prev. Close:
$3.2300
Volume:
232090

Company Statistics

Market Cap.:
$0.092 billion
Book Value:
5.95
Revenue TTM:
$0.014 billion
Operating Margin TTM:
-754%
Gross Profit TTM:
$0.001 billion
Gross Profit TTM:
$0.001 billion
Profit Margin:
0%
Return on Assets TTM:
-27.1%
Return on Equity TTM:
-47.5%

Company Profile

DermTech Inc had its IPO on 2017-08-10 under the ticker symbol DMTK.

The company operates in the LIFE SCIENCES sector and SERVICES-MEDICAL LABORATORIES industry. DermTech Inc has a staff strength of 0 employees.

Stock update

Shares of DermTech Inc opened at $3.22 at the start of the last trading session i.e. 2022-11-02.

The stocks traded within a range of $3.06 - $3.29, and closed at $3.06.

This is a -5.26% slip from the previous day's closing price.

A total volume of 232,090 shares were traded at the close of the day’s session.

In the last one week, shares of DermTech Inc have increased by +2%.

DermTech Inc's Key Ratios

DermTech Inc has a market cap of $0.092 billion, indicating a price to book ratio of 0.557 and a price to sales ratio of 6.5.

In the last 12-months DermTech Inc’s revenue was $0.014 billion with a gross profit of $0.001 billion and an EBITDA of $-0.105 billion. The EBITDA ratio measures DermTech Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, DermTech Inc’s operating margin was -754% while its return on assets stood at -27.1% with a return of equity of -47.5%.

In Q2, DermTech Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 35.7%.

DermTech Inc’s PE and PEG Ratio

Forward PE
-
Trailing PE
-
PEG
None

Its diluted EPS in the last 12-months stands at $-3.159 per share while it has a forward price to earnings multiple of - and a PEG multiple of None. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into DermTech Inc’s profitability.

DermTech Inc stock is trading at a EV to sales ratio of 0.11 and a EV to EBITDA ratio of 0.484. Its price to sales ratio in the trailing 12-months stood at 6.5.

DermTech Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$0.000 billion
Total Liabilities
$0.000 billion
Operating Cash Flow
$0.000 billion
Capital Expenditure
$0.000 billion
Dividend Payout Ratio
0%

DermTech Inc ended 1970 with $0.000 billion in total assets and $131.2 billion in total liabilities. Its intangible assets were valued at $0.000 billion while shareholder equity stood at $0.000 billion.

DermTech Inc ended 1970 with $0.000 billion in deferred long-term liabilities, $0.000 billion in other current liabilities, billion in common stock, $0.000 billion in retained earnings and $0.000 billion in goodwill. Its cash balance stood at $0.000 billion and cash and short-term investments were $0.000 billion. The company’s total short-term debt was $0.000 billion while long-term debt stood at $0.000 billion.

DermTech Inc’s total current assets stands at $0.000 billion while long-term investments were $0.000 billion and short-term investments were $0.000 million. Its net receivables were $0.000 billion compared to accounts payable of $0.000 billion and inventory worth $0.000 billion.

In 1970, DermTech Inc's operating cash flow was $0.000 billion while its capital expenditure stood at $0.000 billion.

Comparatively, DermTech Inc paid $0 billion in dividends in 1970.

Other key metrics

Current Trading Price
$3.06
52-Week High
$30.11
52-Week Low
$2.81
Analyst Target Price
$17.67

DermTech Inc stock is currently trading at $3.06 per share. It touched a 52-week high of $30.11 and a 52-week low of $30.11. Analysts tracking the stock have a 12-month average target price of $17.67.

Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.

Frequently Asked Questions About DermTech Inc

The stock symbol (also called stock or share ticker) of DermTech Inc is DMTK

The IPO of DermTech Inc took place on 2017-08-10

Similar Industry Stocks (SERVICES-MEDICAL LABORATORIES)

Last Price
Chg
Chg%
Veracyte Inc (VCYT)
$19.5
-1.15
-5.57%
$0.19
-0
-2.48%
$2.04
0.14
+7.37%
$0.82
-0.01
-1.2%
$2.2
0.03
+1.38%

Most Active

Last Price
Chg
Chg%
$58.63
-1.03
-1.73%
$92.12
-4.67
-4.82%
$5.12
-0.61
-10.65%
Apple Inc (AAPL)
$145.03
-5.62
-3.73%
$0.06
0.01
+12.74%

Top Gainers

Last Price
Chg
Chg%
$73
42.7
+140.92%
Oi S.A (OIBR-C)
$0
0
+100%
$0.02
0.01
+100%
$0.25
0.1
+66.44%
$2.85
1.01
+54.86%

Top Losers

Last Price
Chg
Chg%
$5.36
-22.58
-80.82%
$0.02
-0.06
-78.67%
Air T, Inc (AIRTW)
$0.01
-0.03
-75%
$4.51
-5.17
-53.41%
$11.5
-12.2
-51.48%

About

DermTech, Inc., a molecular diagnostics company, develops and markets new non-invasive genomic tests to diagnose skin cancer, inflammatory diseases, and age-related conditions in the United States. The company is headquartered in La Jolla, California.

Address

11099 N. TORREY PINES ROAD, SUITE 100, LA JOLLA, CA, US